Published: September 12, 2017

In remarks at the Regulatory Affairs Professionals Society’s (RAPS) 2017 Regulatory Convergence Conference yesterday, U.S.

. . . . . .

Published: September 7, 2017

Commission Settles First-Ever Complaint Against Individual Influencers, Issues Warning Letters to 21 Others, and Releases Updated Staff Guidance

This week, the Federal Trade Commission (FTC or the Commission) pursued enforcement action against a number of social media influencers over the influencers’ alleged failures to disclose material connections between themselves and the brands endorsed in their posts. 

. . . . . .

Published: August 29, 2017

During a campaign-style rally in Arizona last week, President Trump repeated his call for more products to be “Made in the USA.”  Not surprisingly, the President did not address the standards that must be met in order for a product to bear such a claim, or the Federal Trade Commission’s (FTC or the Commission) recent enforcement around the claim.
 

. . . . . .

Published: August 28, 2017

Late last week, groups representing restaurants, grocery stores, and convenience stores reached an agreement with New York City (the City) to ensure that the City will not enforce its analog of the U.S. Food and Drug Administration’s (FDA or the Agency) menu labeling rule against the groups’ members with 20 or more locations nationally until May 7, 2018, the compliance date of the Agency’s rule.

. . . . . .

Published: August 16, 2017

This week, there were developments in two menu labeling lawsuits about which we reported previously: a lawsuit challenging the U.S.

. . . . . .

Published: July 31, 2017

On July 28, 2017, the U.S. Food and Drug Administration (FDA or the Agency) announced a new, comprehensive plan for tobacco and nicotine regulation that will place nicotine, and the issue of addiction, at the center of the Agency’s tobacco regulatory efforts.

. . . . . .

Published: July 21, 2017

Last week, the U.S. House of Representatives (the House) passed by voice vote the FDA Reauthorization Act of 2017 (FDARA or the Act). Introduced on May 16, 2017 by House Energy and Commerce Committee Chairman Greg Walden (R-Ore.), Ranking Member Frank Pallone (D-NJ), and Health Subcommittee Ranking Member Rep. Gene Green (D-TX), the Act would reauthorize four key U.S.

. . . . . .

Published: July 20, 2017

The Federal Trade Commission (FTC or the Commission) announced a wave of reforms this week in line with Acting Chairman Maureen K. Ohlhausen’s mission to “aggressively” implement a Trump administration directive aimed at eliminating wasteful, unnecessary regulations and processes.

. . . . . .

Published: July 19, 2017

The U.S. Food and Drug Administration’s (FDA or the Agency) decision a couple of months ago to delay its Menu Labeling Rule until May 7, 2018, as discussed here, was met with mixed reactions from industry.

. . . . . .

Published: July 5, 2017

As marijuana related businesses can attest, finding a bank or credit union that will provide financial services can be particularly challenging. After all, money earned from the production or sale of the Schedule I drug is federally illegal. While financial institutions can provide such businesses with accounts, under federal laws, banks must disclose marijuana-related transactions as suspicious activity. The U.S. Department of the Treasury (Treasury Department) allows banks to work with legal marijuana entities under limited circumstances but most lenders still hesitate.

. . . . . .